In colorectal cancer, miR-32-5p primarily targets BMP5 (Bone Morphogenetic Protein 5), a tumor suppressor involved in TGF-β signaling and epithelial-mesenchymal transition regulation [37, 38]. This evidence concerns the gene BMP5 and neoplasm.